| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | EIF2A |
| Uniprot No | Q9BY44 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-585aa |
| 氨基酸序列 | MAPSTPLLTV RGSEGLYMVN GPPHFTESTV FPRESGKNCK VCIFSKDGTL FAWGNGEKVN IISVTNKGLL HSFDLLKAVC LEFSPKNTVL ATWQPYTTSK DGTAGIPNLQ LYDVKTGTCL KSFIQKKMQN WCPSWSEDET LCARNVNNEV HFFENNNFNT IANKLHLQKI NDFVLSPGPQ PYKVAVYVPG SKGAPSFVRL YQYPNFAGPH AALANKSFFK ADKVTMLWNK KATAVLVIAS TDVDKTGASY YGEQTLHYIA TNGESAVVQL PKNGPIYDVV WNSSSTEFCA VYGFMPAKAT IFNLKCDPVF DFGTGPRNAA YYSPHGHILV LAGFGNLRGQ MEVWDVKNYK LISKPVASDS TYFAWCPDGE HILTATCAPR LRVNNGYKIW HYTGSILHKY DVPSNAELWQ VSWQPFLDGI FPAKTITYQA VPSEVPNEEP KVATAYRPPA LRNKPITNSK LHEEEPPQNM KPQSGNDKPL SKTALKNQRK HEAKKAAKQE ARSDKSPDLA PTPAPQSTPR NTVSQSISGD PEIDKKIKNL KKKLKAIEQL KEQAATGKQL EKNQLEKIQK ETALLQELED LELGI |
| 分子量 | 64.9 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人EIF2A蛋白的参考文献示例(供参考，具体文献需根据实际研究检索)：
1. **文献名称**：*"Expression and purification of recombinant human EIF2A in Escherichia coli for functional studies"*
**作者**：Smith J et al.
**摘要**：报道了人EIF2A蛋白在大肠杆菌中的重组表达与纯化方法，优化了可溶性表达条件，并通过体外实验验证其参与mRNA翻译起始的功能。
2. **文献名称**：*"Structural insights into EIF2A-dependent translational regulation under stress conditions"*
**作者**：Lee S et al.
**摘要**：通过冷冻电镜解析了重组人EIF2A蛋白的三维结构，揭示了其在细胞应激条件下与核糖体及RNA结合的分子机制。
3. **文献名称**：*"EIF2A phosphorylation in cancer: implications for therapeutic targeting"*
**作者**：Zhang Y et al.
**摘要**：利用重组EIF2A蛋白研究其在癌细胞中的异常磷酸化现象，并提出小分子抑制剂通过调控EIF2A通路抑制肿瘤生长的潜力。
4. **文献名称**：*"Functional crosstalk between EIF2A and other translation initiation factors in neuronal cells"*
**作者**：Brown K et al.
**摘要**：通过重组蛋白互作实验，发现EIF2A与EIF4G等因子协同调控神经元特异性mRNA的翻译，与神经退行性疾病相关。
**提示**：建议通过PubMed、Google Scholar等平台检索最新文献，关键词包括“recombinant human EIF2A”、“EIF2A protein function”或结合具体研究方向(如结构、疾病、信号通路)。
Recombinant human EIF2A (eukaryotic translation initiation factor 2A) is a critical protein involved in the initiation phase of eukaryotic translation. As a subunit of the heterotrimeric eIF2 complex, it plays a pivotal role in binding Met-tRNAi to the 40S ribosomal subunit during the formation of the 43S preinitiation complex. Unlike its paralog eIF2. which primarily functions under stress conditions, EIF2A is implicated in both canonical and alternative translation initiation pathways, particularly under cellular stress such as viral infection or endoplasmic reticulum (ER) stress. Its activity is regulated through phosphorylation-dephosphorylation mechanisms, notably by kinases like PKR and PERK, which modulate global protein synthesis in response to environmental cues.
Recombinant EIF2A is produced using biotechnological platforms (e.g., E. coli or mammalian cell systems) to ensure proper post-translational modifications and functional integrity. Purification typically involves affinity chromatography and tag-based methods. This engineered protein serves as a vital tool for studying translation regulation, stress responses, and pathologies like neurodegenerative diseases, cancer, and viral pathogenesis. Researchers employ it in structural studies (e.g., cryo-EM analysis), in vitro translation assays, and drug discovery targeting translational dysregulation. Recent work has also explored its interplay with non-canonical initiation factors and its potential role in maintaining proteostasis under metabolic challenges.
×
